Related Experiment Video
Updated: Jul 3, 2025
08:34
A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening
Published on: October 16, 2015
10.0K
Research on the Interaction Mechanism and Structural Changes in Human Serum Albumin with Hispidin Using Spectroscopy
Si-Hua Fan1,2, Wen-Qiang Wang1,2, Yu-Wen Zhou2
1College of Biology and Food Engineering, Guangdong University of Petrochemical Technology, No. 1, Kechuang Road, Maonan District, Maoming 525000, China.
Molecules (Basel, Switzerland)
|February 10, 2024
Summary
Hispidin, a mushroom compound, binds to human serum albumin (HSA) primarily through hydrophobic interactions at site I. This interaction was confirmed using fluorescence, spectroscopy, and molecular docking, revealing key binding parameters.
Area of Science:
- Biochemistry
- Molecular Interactions
- Pharmacology
Background:
- Human serum albumin (HSA) is a crucial carrier protein in the bloodstream.
- Hispidin is a bioactive polyketide found in edible and therapeutic mushrooms.
- Understanding drug-protein interactions is vital for drug development and efficacy.
Purpose of the Study:
- To investigate the binding mechanism and characteristics between human serum albumin (HSA) and hispidin.
- To determine the binding site and the forces governing the interaction.
- To provide insights into the pharmacokinetic behavior of hispidin.
Main Methods:
- Multispectral methods including fluorescence quenching, synchronous fluorescence, and UV/vis spectroscopy.
- Hydrophobic probe assays and detergent-based experiments.
- Site competition assays and molecular docking simulations.
Main Results:
- Hispidin non-covalently binds to HSA via a static quenching mechanism.
- The interaction is predominantly driven by hydrophobic forces, indicated by positive thermodynamic parameters (ΔH and ΔS).
- Molecular docking and site competition studies confirmed binding to site I (IIA domain) of HSA.
Conclusions:
- Hispidin interacts with human serum albumin (HSA) at a specific site (IIA domain) through hydrophobic forces.
- The binding is characterized by static quenching and is influenced by temperature.
- These findings contribute to understanding the pharmacokinetics and potential therapeutic applications of hispidin.
Related Concept Videos
01:22Protein-Drug Binding: Determination Methods
181
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
181
01:16Protein-Drug Binding: Mechanism and Kinetics
477
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
477
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
107
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
107
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
160
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
160
02:18The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
01:30Drug Binding to Blood Components
149
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
149